JP Morgan Chase & Co’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.48M | Sell |
|
|||||
|
2025
Q2 | $986K | Sell |
|
|||||
|
2025
Q1 | $741K | Sell |
|
|||||
|
2024
Q4 | $938K | Sell |
|
|||||
|
2024
Q3 | $2.52M | Buy |
|
|||||
|
2024
Q2 | $2.06M | Buy |
|
|||||
|
2024
Q1 | $2.41M | Sell |
|
|||||
|
2023
Q4 | $1.42M | Sell |
|
|||||
|
2023
Q3 | $2.2M | Buy |
|
|||||
|
2023
Q2 | $3.92M | Buy |
|
|||||
|
2023
Q1 | $6.76M | Sell |
|
|||||
|
2022
Q4 | $8.45M | Buy |
|
|||||
|
2022
Q3 | $8.95M | Sell |
|
|||||
|
2022
Q2 | $8.4M | Buy |
|
|||||
|
2022
Q1 | $2.81M | Buy |
|
|||||
|
2021
Q4 | $2.79M | Sell |
|
|||||
|
2021
Q3 | $2.14M | Sell |
|
|||||
|
2021
Q2 | $1.67M | Sell |
|
|||||
|
2021
Q1 | $1.94M | Sell |
|
|||||
|
2020
Q4 | $1.86M | Sell |
|
|||||
|
2020
Q3 | $2.06M | Sell |
|
|||||
|
2020
Q2 | $2.37M | Buy |
|
|||||
|
2020
Q1 | $2.41M | Sell |
|
|||||
|
2019
Q4 | $3.48M | Sell |
|
|||||
|
2019
Q3 | $3.65M | Sell |
|
|||||
|
2019
Q2 | $9.15M | Buy |
|
|||||
|
2019
Q1 | $5.46M | Sell |
|
|||||
|
2018
Q4 | $5.5M | Buy |
|
|||||
|
2018
Q3 | $4.71M | Sell |
|
|||||
|
2018
Q2 | $7.94M | Sell |
|
|||||
|
2018
Q1 | $8.26M | Sell |
|
|||||
|
2017
Q4 | $9.76M | Buy |
|
|||||
|
2017
Q3 | $5.34M | Sell |
|
|||||
|
2017
Q2 | $5M | Buy |
|
|||||
|
2017
Q1 | $3.4M | Sell |
|
|||||
|
2016
Q4 | $4.62M | Sell |
|
|||||
|
2016
Q3 | $3.7M | Buy |
|
|||||
|
2016
Q2 | $4K | Sell |
|
|||||
|
2016
Q1 | $12K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $1.39M | Buy |
|